Back

Implantable cardioverter-defibrillator in channelopathies: head-to-head comparison between the transvenous and subcutaneous defibrillator

20 March 2018 (12:00 - 12:10)
Organised by:
Congress Presentation Part of: Shocking truths regarding implantable cardioverter defibrillators Implantable Cardioverter / Defibrillator EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Boris Rudic

Hospital Frankfurt Hochst, Frankfurt am Main (Germany)

8 More presentations in this session

Presentation thumbnail
Striking difference between cardiac sub-specialties during consideration for implantable cardioverter defibrillators
Doctor A. Mistry (Nottingham, GB)
Abstract Slides Video
Presentation thumbnail
The destiny of abandoned transvenous ICD leads
Mr A. Elgaard (Aalborg, DK)
Abstract
Presentation thumbnail
FRAGILE (French Attitude Registry in case of ICD Lead Replacement) preliminary results.
Doctor C. Alonso (Neuilly sur Seine, FR)
Abstract Slides Video
Presentation thumbnail
Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.
Doctor V. Galand (Rennes, FR)
Abstract
Presentation thumbnail
Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator. Less is more. Data from the German Device Registry
Doctor H. Bogossian (Hagen, DE)
Abstract

Access the full session

Session thumbnail
Shocking truths regarding implantable cardioverter defibrillators

The Event

Event poster

EHRA 2018

20 March 2018 12:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources